Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Effect of Inhaled Hydroxy Gas on Long COVID Symptoms

  • Read more about Effect of Inhaled Hydroxy Gas on Long COVID Symptoms

Stem Cell Study for Long COVID-19 Neurological Symptoms

  • Read more about Stem Cell Study for Long COVID-19 Neurological Symptoms

Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

  • Read more about Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine

  • Read more about Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine

Effects of Aerobic Exercise in Patients With Post COVID-19

  • Read more about Effects of Aerobic Exercise in Patients With Post COVID-19

Bright Light Therapy for Post-COVID-19 Fatigue

  • Read more about Bright Light Therapy for Post-COVID-19 Fatigue

NC Testing in LC & POTS

  • Read more about NC Testing in LC & POTS

Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers

  • Read more about Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers

Intradermal COVID-19 Vaccination in the Immunocompromised

  • Read more about Intradermal COVID-19 Vaccination in the Immunocompromised

Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age

  • Read more about Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 89
  • Page 90
  • Page 91
  • Page 92
  • Current page 93
  • Page 94
  • Page 95
  • Page 96
  • Page 97
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA